Cargando…
Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells
BACKGROUND: Glioblastoma (GBM) is the most common primary brain malignancy and confers a dismal prognosis. GBMs harbor glioblastoma-initiating cells (GICs) that drive tumorigenesis and contribute to therapeutic resistance and tumor recurrence. Consequently, there is a strong rationale to target this...
Autores principales: | Mughal, Awais A., Grieg, Zanina, Skjellegrind, Håvard, Fayzullin, Artem, Lamkhannat, Mustapha, Joel, Mrinal, Ahmed, M. Shakil, Murrell, Wayne, Vik-Mo, Einar O., Langmoen, Iver A., Stangeland, Biljana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546247/ https://www.ncbi.nlm.nih.gov/pubmed/26292663 http://dx.doi.org/10.1186/s12943-015-0432-z |
Ejemplares similares
-
Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells
por: Stangeland, Biljana, et al.
Publicado: (2015) -
Expansion of Multipotent Stem Cells from the Adult Human Brain
por: Murrell, Wayne, et al.
Publicado: (2013) -
Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo
por: Joel, Mrinal, et al.
Publicado: (2015) -
Phenotypic and Expressional Heterogeneity in the Invasive Glioma Cells()()
por: Fayzullin, Artem, et al.
Publicado: (2018) -
Short-Term Differentiation of Glioblastoma Stem Cells Induces Hypoxia Tolerance
por: Skjellegrind, Håvard K., et al.
Publicado: (2016)